Healthcare stocks have been out of vogue with investors since late 2022. Myriad reasons underlie the negative sentiment ...

As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the branded pharmaceuticals ...

Biotech company Immunai, which developed an AI-based immune system mapping technology for drug development, announces the ...

Goldman Sachs estimates that AI drug discovery and breakthroughs like gene editing will add 0.5% to 2.5% to the U.S. gross ...

Years after the biopharmaceutical industry stepped up to create COVID-19 vaccines as the virus spiraled into a global ...

What drew you to pursue a career in oncology and what is it that inspires you most about working in this field?

SPR720 is an investigational, chemically stable phosphate ester prodrug that is converted rapidly in vivo to SPR719, the ...

Investing.com -- Pfizer Inc. (NYSE: PFE) stock fell 1.5% following reports that U.S. prosecutors are investigating a claim ...

In a business where drug development needs many shots on goal to be successful, Pfizer has the financial resources and established research power to support the development of innovative new drugs.

The inquiry is looking into a politically explosive suggestion that Pfizer delayed announcing a successful vaccine against ...